A detailed history of Centiva Capital, LP transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 35,244 shares of TLRY stock, worth $58,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,244
Holding current value
$58,152
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.6 - $2.48 $56,390 - $87,405
35,244 New
35,244 $87,000
Q3 2023

Nov 14, 2023

BUY
$1.55 - $3.31 $42,260 - $90,247
27,265 New
27,265 $65,000
Q1 2022

May 16, 2022

SELL
$4.88 - $8.56 $623,917 - $1.09 Million
-127,852 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.03 - $13.03 $898,799 - $1.67 Million
127,852 New
127,852 $899,000
Q2 2020

Aug 14, 2020

SELL
$5.54 - $10.81 $60,147 - $117,364
-10,857 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$2.47 - $21.36 $26,816 - $231,905
10,857 New
10,857 $75,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $1.01B
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.